HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

4 weeks ago

Results of Q2 2024, including settlement of long-running arbitration.

Ticker	Sentiment	Impact
IBRX	Neutral	4 %
HCWB	Neutral	18 %